Evidence map›Paper›PMID 42552076›Full record

ArticleBMJ case reports2026

Delayed diagnosis of primary cutaneous histoplasmosis in a patient receiving tumour necrosis factor alpha inhibitor therapy.

Harika Kalangi, Shivesh K Goyal, Hind El Soufi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harika KalangiDivision of Infectious Diseases, Northwell Health, New Hyde Park, New York, USA hkalangi@northwell.edu.ORCID http://orcid.org/0000-0001-9298-9028
Shivesh K GoyalDepartment of Biological Chemistry and Psychology, Stony Brook University, Stony Brook, New York, USA.
Hind El SoufiDivision of Infectious Diseases, Northwell Health, New Hyde Park, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cutaneous histoplasmosis (PCH) is a rare fungal infection, often misdiagnosed due to its polymorphic skin manifestations. We describe a woman in her 60s with rheumatoid arthritis receiving infliximab and long-term prednisone who presented with progressive, non-healing lesions of the left forearm. Initially treated as cellulitis without improvement, further investigation led to a diagnosis of PCH due to

Indexed as

Arthritis, RheumatoidDermatomycosesHistoplasmosisAntifungal AgentsAntirheumatic AgentsDelayed DiagnosisFemaleHistoplasmaHumansImmunocompromised HostInfliximabMiddle AgedPrednisoneTreatment OutcomeTumor Necrosis Factor-alphaAntifungal AgentsAntirheumatic AgentsInfliximabPrednisoneTumor Necrosis Factor-alphaFungal InfectionsInfectious diseases

Identifiers

PMID42552076
PMCPMC13448003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.